To evaluate the effect of curcumin in the acute phase of zymosan-induced arthritis.
Introduction
Arthritis is a degenerative joint disease with a high prevalence and is a major cause of disability worldwide 1 . The continuous inflammatory process leads to progressive destruction of the cartilage, bone changes and chronic inflammation of the synovial membranes. The intense and continuous pain in the involved joints limits movements and results in the patient becoming depressed and isolated from his/her social life 2, 3 .
In addition to interfering with the quality of life, arthritis has a substantial impact on treatment and medical care costs 4 .
Arthritis can affect any joint. However, in descending order, the knees are the most commonly affected joints, followed by the hips, hands, spine, wrists and ankles 3 . It is estimated that 35% of individuals over 30 years of age already show clinical and radiological signs of arthritis in the knees and that 85% of patients over 70 years of age have radiographic changes in their knee joints that allow the diagnosis of disease 1, 3 . Although the etiology of arthritis is still uncertain, some risk factors have been related to its pathogenesis, including age, endocrine and metabolic disorders, ethnic, genetic and mechanical trauma New substances are constantly being tested, showing activity against arthritis both in vitro and in vivo.
A natural substance that has shown amazing effects for the treatment of osteoarthritis is curcumin, the active ingredient extracted from the root of Curcuma longa (Indian curry), which was already used by Ayurvedic medicine 8 . Among the many potential uses of the curcumin, its intense antioxidant activity stands out 9, 10 .
When considering that there is a significant formation of ROS by the synovium in patients with arthritis, it is possible that curcumin will be useful in treating this disease 11 . It is possible that the antioxidant effects of curcumin can minimize oxidative damage to the articular cartilage and improve the symptoms of the disease.
However, to the best of our knowledge, the anti-inflammatory effects of curcumin have not been tested in experimental models of zymosan-induced arthritis [12] [13] [14] . Thus, the aim of this study was to determine whether oral administration of curcumin enhances the acute inflammatory response in experimental arthritis.
Methods
This study was approved in accordance with Federal 
Arthritis induction
The experiment was started at 6 o'clock in the morning.
The animals were initially weighed, and the induction of arthritis was always performed under general anesthesia by intraperitoneal administration of 0.1 ml/100 g of a 1:1 (v/v) solution of ketamine (50 mg/ml) and xylazine (20 mg/ml). The induction of the arthritis was performed on 24 animals of the experimental group and four of the positive control group by infiltration of 0.05 mL zymosan (1 mg/50 µL) in both knee joints using disposable insulin syringes.
Four animals of the negative control group received the same intra-articular volume of saline.
Experimental groups
The animals were divided into the following five groups: A)
Positive control: after the induction of arthritis, the animals received gastric gavage with corn oil every six hours for 48 hours (n=4); B)
Negative control: the rats received intra-articular infiltration with saline in both knees and gastric gavage with corn oil every six hours for 48 hours (n=4); C) Curcumin: after the induction of arthritis, the animals received gastric gavage every six hours for 48 hours with curcumin (Sigma-Aldrich Ltd., USA) at dose 100 mg/kg (n=8); D) after the induction of arthritis, the rats received gastric gavage every six hours for 48 hours with prednisone at dose of 1 mg/kg/day (n=8); E) after the induction of the arthritis, the animals received gastric gavage every six hours for 48 hours with prednisone at dose of 8 mg/kg/day (n=8). The animals in all experimental groups were sacrificed after six, 12, 24 and 48 hours.
After sacrifice, tissue samples containing the cartilage and synovial of both knees were removed. Fragments prepared for histological analysis were immersed in 10% neutral buffered formalin (Sigma, St. Louis, MO, USA) for 24 h, dehydrated in increasing ethanol concentrations, and embedded in paraffin.
Thereafter, 5-µm sections of tissue were cut using a rotary microtome (Leica Biosystems, Nussloch, Germany), mounted on glass slides, cleared, hydrated and stained with hematoxylin-eosin (HE) for histological evaluation. Slide analysis was performed by a pathologist experienced in arthritis who was unaware of the source material and the objectives of the study using an optical microscope (Eclipse DS-50, Nikon Inc., Osaka, Japan).
Photomicrographs were taken with a digital video-capture camera (DS-Fi-50; Nikon Inc., Osaka, Japan) coupled to the microscope body. The number of neutrophils per field was measured by computer-assisted image analysis system (NIS-Elements; Nikon
Inc., Osaka, Japan), evaluating the image of three random fields in each histological slide. The final value adopted for each slide was
represented by the median of the values found in the evaluation of the three selected fields.
The intensity of the inflammatory infiltrate was graded in crosses (from -to 6+) according to the number of neutrophils founded in each histological fields. The final value adopted for each animal was the average found after analysis of three distinct histological fields and represents the inflammatory grade.
According to the points obtained in the inflammatory grade, graduation was stratified as absent (0), mild (1 and 2), moderate (3 and 4) and severe (5 and 6) , to what is called the degree of inflammation ( Table 1) . Results Figure 1A shows the synovial membrane and articular cartilage removed from a normal animal's knee in the negative control group (not subjected to infiltration with zymosan). Figure  1B shows the articular cartilage and the synovia of a knee removed from an animal in the control positive group after six hours of gastric gavage with corn oil.
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Nonose N et al. Figure 2A shows the articular cartilage and synovial membrane removed from an animal in the experimental group subjected to gastric gavage with curcumin (100 mg/kg) after six hours of articular-induced arthritis with zymosan. Figure 2B shows the articular cartilage and synovial membrane removed from an animal in the experimental group subjected to gastric gavage with curcumin (100 mg/kg) after 48 hours of articular-induced arthritis with zymosan. Figure 4A shows the articular cartilage and synovial membrane removed from an animal in the experimental group subjected to gastric gavage with prednisone (8 mg/kg) after six hours of induction of arthritis with zymosan. Figure 4B shows the articular cartilage and synovial membrane removed from an animal in the experimental group subjected to gastric gavage with prednisone (8 mg/kg) after 48 hours of articular-induced arthritis with zymosan. FIGURE 1 -A: Synovial membrane and articular cartilage from animal's knee after six hours of negative control group showing without neutrophil infiltration (HE x100). B: Synovial membrane and articular cartilage from animal's knee after six hours of positive control group showing severe neutrophil infiltrate (HE x100). Table 3 shows the variations in the inflammatory scores in animals of the positive control and experimental groups subjected to gastric gavage with corn oil, curcumin (100 mg/kg), and different concentrations of prednisone (1 mg/kg, 8 mg/kg) at different time points during the experiment.
Oral administration of curcumin (Curcuma longa) can attenuate the neutrophil inflammatory response in zymosan-induced arthritis in rats
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Discussion
The main objective of the treatment of different forms of arthritis is to reduce inflammation within the joints 15 . There are several drugs that meet that goal, and among them, substances that interrupt the inflammatory cascade deserve a prominent place. For decades, the use of substances with anti-inflammatory action has been the main treatment option. The anti-inflammatory medications can be divided into the following two major groups:
steroids and non-steroids substances.
Different types of GC mainly represent the steroids class. With the aim of finding natural substances that exhibit anti-inflammatory activity in the treatment of arthritis and that exhibit minimal side effects, the efficacies of a number of natural substances are being increasingly tested in experimental models of arthritis 16, 17 . Among these substances, curcumin, derived from the root of the plant Curcuma longa, which is rich in diferuloylmethane, has been one of the most promising natural active ingredients [17] [18] [19] .
Its use for the treatment of various inflammatory diseases, including arthritis, has already been described for thousands of years by Ayurvedic medicine and traditional Chinese medicine 
19
, evaluated increasing doses of curcumin (30, 60 and 110 mg/mL/kg) associated with GC (betamethasone at a dose of 0.5 mg/mL/kg) applied orally daily for four weeks in an experimental model of collagen-induced arthritis. They showed that there was significant improvement in inflammatory score, radiographic score and erythrocyte sedimentation rate in animals treated with the higher doses. However, the main criticism is that the study cannot evaluate if the effect is due to curcumin alone or, more likely, the synergism between the two substances. Ramadan et al. 22 , compared the anti-inflammatory and antioxidant roots of curcumin and ginger, both at a dose of 200 mg/kg, in an experimental model of adjuvant-induced arthritis. They found that both rhizomes were able to reduce the incidence and severity of arthritis by increasing and decreasing proinflammatory and anti-inflammatory cytokines, respectively, and activating the antioxidant defense systems. When compared to curcumin extract of ginger and indomethacin, they found that curcumin showed an anti-arthritic effect that was superior that of other substances, particularly when administered from the day of the induction of arthritis. They concluded that the results proved that the anti-inflammatory and antioxidant effects of curcumin are stronger than those of ginger and indomethacin. Its low cost and lack of adverse effects make the substance potentially effective in treating arthritis 22 . Phase 1 studies have shown that even high doses of curcumin (12 g/day), although safe, present with low availability in serum 16 . Because the extract of Curcuma longa is not water soluble, we chose to dissolve it in corn oil. Other authors have chosen to dissolve the plant extract in olive oil 19 . Therefore, it is possible that the vehicle used has also interfered with the absorption. A previous study demonstrated that the use of pure oral powder of a commercialized extract containing 94% of the three main curcuminoids is more potent in preventing arthritis than essential oil substances 31 . It is possible that the administration of curcumin parenteral could provide higher availability; however, this type of administration diminishes the advantage of using the substance over other drug options for the treatment of arthritis.
The use of nanoparticles or curcumin involved in phospholipid complexes, or the synthesis of analogous substances, appears to have solved the problems of low bioavailability because they favor the absorption and metabolism delay 31 .
In this this study when were counted the number of However, after 12 and 24 hours, the anti-inflammatory effects of curcumin become similar to those of prednisone at both doses and do not alter the degree of inflammation. These findings may be related to low plasma and tissue levels of curcumin due to the low absorption by the digestive tract, and rapid systemic metabolism and elimination 18 . It is possible that the use of drugs by the parenteral route, dissolved in lipid vehicles capable of intravenous administration, can enhance the activity of the substance during that period.
The results of this study suggest that curcumin may be a useful drug for treating the acute phase of arthritis; however, additional studies have to be performed to improve the effectiveness of the substance. Research comparing increasing concentrations of the drug through different routes of administration, and especially improving their bioavailability, are still required to enable the use of curcumin.
Conclusion
Oral administration of curcumin may be a useful strategy for treating the initial phase of zymosan-induced arthritis.
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